Catalyst Wire Dossier Catalyst Wire Dossier

BENLYSTA

belimumab · GlaxoSmithKline LLC
Drug timelines are a Plus or Pro feature.

51 regulatory and trial events tracked for BENLYSTA, covering 2011-03-09 to 2026-08-21. Get the full timeline:

Most recent: FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)

See pricing